{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T03:45:06Z","timestamp":1784864706141,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003482","name":"Department of Education of Hebei Province","doi-asserted-by":"publisher","award":["BJK2024144"],"award-info":[{"award-number":["BJK2024144"]}],"id":[{"id":"10.13039\/501100003482","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008047","name":"Hebei University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020752","name":"Hebei University of Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020752","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.bioorg.2025.108591","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T19:20:54Z","timestamp":1747336854000},"page":"108591","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Design, synthesis, and biological evaluation of novel 2-substituted aniline pyrimidine derivatives as potential and orally bioavailable Mer inhibitors with antitumor activities"],"prefix":"10.1016","volume":"162","author":[{"given":"Jixia","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daowei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bioorg.2025.108591_bb0005","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13046-024-02992-2","article-title":"Inhibition of MER proto-oncogene tyrosine kinase by an antisense oligonucleotide enhances treatment efficacy of immunoradiotherapy","volume":"43","author":"Hu","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2025.108591_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113534","article-title":"UNC5293, a potent, orally available and highly MERTK-selective inhibitor","volume":"220","author":"Zheng","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108591_bb0015","first-page":"35","article-title":"TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human Cancer, advances in Cancer research","volume":"100","author":"Linger","year":"2008","journal-title":"Academic Press: New York"},{"issue":"7","key":"10.1016\/j.bioorg.2025.108591_bb0020","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1021\/acs.jmedchem.4c00148","article-title":"Discovery of novel macrocyclic MERTK\/AXL dual inhibitors","volume":"67","author":"Kong","year":"2024","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108591_bb0025","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/s41571-023-00813-7","article-title":"TAM family kinases as therapeutic targets at the interface of cancer and immunity","volume":"20","author":"DeRyckere","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"23","key":"10.1016\/j.bioorg.2025.108591_bb0030","doi-asserted-by":"crossref","first-page":"9683","DOI":"10.1021\/jm401387j","article-title":"Pseudo-cyclization through intramolecular hydrogen bond enables discovery of pyridine substituted pyrimidines as new Mer kinase inhibitors","volume":"56","author":"Zhang","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108591_bb0035","doi-asserted-by":"crossref","DOI":"10.1038\/onc.2012.355","article-title":"Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer","volume":"32","author":"Linger","year":"2013","journal-title":"Oncogene"},{"issue":"7493","key":"10.1016\/j.bioorg.2025.108591_bb0040","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nature12998","article-title":"The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells","volume":"507","author":"Paolino","year":"2014","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.bioorg.2025.108591_bb0045","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1158\/1535-7163.MCT-13-0040","article-title":"UNC569, a novel small-molecule mer inhibitor with efficacy against acute lymphoblastic leukemia in vitro and in vivo","volume":"12","author":"Christoph","year":"2013","journal-title":"Mol. Cancer Ther."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108591_bb0050","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1021\/ml200239k","article-title":"Discovery of small molecule mer kinase inhibitors for the treatment of pediatric acute lymphoblastic leukemia","volume":"3","author":"Liu","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108591_bb0055","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1007\/s11095-023-03596-9","article-title":"Constitutively synergistic multiagent drug formulations targeting MERTK, FLT3, and BCL-2 for treatment of AML","volume":"40","author":"Kelvin","year":"2023","journal-title":"Pharm. Res."},{"issue":"17","key":"10.1016\/j.bioorg.2025.108591_bb0060","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.3390\/cells11172752","article-title":"Inhibition of Mcl-1 synergistically enhances the Antileukemic activity of Gilteritinib and MRX-2843 in preclinical models of FLT3-mutated acute myeloid leukemia","volume":"11","author":"Wu","year":"2022","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108591_bb0065","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.85630","article-title":"The MERTK\/FLT3 inhibitor MRX-2843 overcomes resistance-conferring FLT3 mutations in acute myeloid leukemia","volume":"1","author":"Minson","year":"2016","journal-title":"JCI Insight"},{"issue":"23","key":"10.1016\/j.bioorg.2025.108591_bb0070","doi-asserted-by":"crossref","first-page":"9683","DOI":"10.1021\/jm401387j","article-title":"Pseudo-cyclization through intramolecular hydrogen bond enables discovery of pyridine substituted pyrimidines as new Mer kinase inhibitors","volume":"56","author":"Zhang","year":"2013","journal-title":"J. Med. Chem."},{"issue":"13","key":"10.1016\/j.bioorg.2025.108591_bb0075","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1016\/j.bmc.2016.05.025","article-title":"Synthesis, biological evaluation, and physicochemical property assessment of 4-substituted 2-phenylaminoquinazolines as Mer tyrosine kinase inhibitors","volume":"24","author":"Wang","year":"2016","journal-title":"Bioorg. Med. Chem."},{"issue":"Part_1","key":"10.1016\/j.bioorg.2025.108591_bb0080","article-title":"Synthesis, properties, and application of various ferrocene-incorporated ureas: a comprehensive review","volume":"1319","author":"Jancic","year":"2025","journal-title":"J. Mol. Struct."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108591_bb0085","first-page":"1822","article-title":"Structure-activity relationship of 7-aryl-2-anilino-pyrrolopyrimidines as Mer and Axl tyrosine kinase inhibitors","volume":"35","author":"Chung","year":"2020","journal-title":"J. Med. Chem."},{"issue":"22","key":"10.1016\/j.bioorg.2025.108591_bb0090","doi-asserted-by":"crossref","first-page":"9929","DOI":"10.1021\/jm3011299","article-title":"Structure\u2013activity studies of 7-heteroaryl-3-azabicyclo [3.3.1] non-6-enes: a novel class of highly potent nicotinic receptor ligands","volume":"55","author":"Breining","year":"2012","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108591_bb0095","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1021\/jm800994j","article-title":"A series of halogenated heterodimeric inhibitors of prostate specific membrane antigen (PSMA) as radiolabeled probes for targeting prostate cancer","volume":"52","author":"Maresca","year":"2009","journal-title":"J. Med. Chem."},{"issue":"25","key":"10.1016\/j.bioorg.2025.108591_bb0100","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1002\/anie.200801465","article-title":"A general and efficient method for the Suzuki-Miyaura coupling of 2-pyridyl nucleophiles","volume":"47","author":"Billingsley","year":"2008","journal-title":"Angew. Chem. Int. Ed."},{"issue":"44","key":"10.1016\/j.bioorg.2025.108591_bb0105","doi-asserted-by":"crossref","first-page":"9675","DOI":"10.1039\/D1OB02000E","article-title":"Predictable site-selective functionalization: promoter group assisted Para-halogenation of N-substituted (hetero) aromatics under metal-free condition","volume":"19","author":"Gupta","year":"2021","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2025.108591_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114577","article-title":"Hit-to-lead optimization of novel phenyl imidazole carboxamides that are active against Leishmania donovani","volume":"240","author":"McNamara","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108591_bb0115","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1186\/s12885-022-09612-2","article-title":"Stimulating TAM-mediated anti-tumor immunity with mannose-decorated nanoparticles in ovarian cancer","volume":"22","author":"Glass","year":"2022","journal-title":"BMC Cancer"},{"issue":"12","key":"10.1016\/j.bioorg.2025.108591_bb0120","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrc3847","article-title":"The TAM family: phosphatidylserine-sensing receptor tyrosine kinases gone awry in cancer","volume":"14","author":"Graham","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2025.108591_bb0125","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ejmech.2015.10.003","article-title":"State-of-the-art of small molecule inhibitors of the TAM family: the point of view of the chemist","volume":"105","author":"Baladi","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108591_bb0130","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1158\/0008-5472.CAN-20-2066","article-title":"Axl and Mertk receptors cooperate to promote breast cancer progression by combined oncogenic signaling and evasion of host antitumor immunity","volume":"81","author":"Davra","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2025.108591_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113648","article-title":"Structure-guided design and development of novel N-phenylpyrimidin-2-amine derivatives as potential c-met inhibitors","volume":"223","author":"Huang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108591_bb0140","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3390\/molecules29020475","article-title":"Design, synthesis, and biological evaluation of 2-substituted aniline pyrimidine derivatives as potent dual Mer\/c-met inhibitors","volume":"29","author":"Huang","year":"2024","journal-title":"Molecules"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825004717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825004717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T02:23:51Z","timestamp":1762223031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825004717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":28,"alternative-id":["S0045206825004717"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108591","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and biological evaluation of novel 2-substituted aniline pyrimidine derivatives as potential and orally bioavailable Mer inhibitors with antitumor activities","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108591","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108591"}}